We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAS icon
1676
Masco
MAS
$14.7B
$232K 0.01%
4,182
-35,889
-90% -$2.13M
NULC icon
1677
Nuveen ESG Large-Cap ETF
NULC
$72.9M
$232K 0.01%
5,728
-25,701
-82% -$1.06M
SKIN icon
1678
SkinHealth Systems
SKIN
$83.3M
$232K 0.01%
8,951
-6,180
-41% -$136K
TREE icon
1679
LendingTree
TREE
$453M
$232K 0.01%
1,659
-352
-18% -$61.7K
XAIR icon
1680
Beyond Air
XAIR
$3.75M
$232K 0.01%
52
+43
+478% +$156K
AVIR icon
1681
Atea Pharmaceuticals
AVIR
$402M
$231K 0.01%
6,589
+4,908
+292% +$136K
CTSO icon
1682
Cytosorbents Corp
CTSO
$22.7M
$231K 0.01%
28,447
-327
-1% -$2.66K
CRXT
1683
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$231K 0.01%
+43,345
New +$390K
BLUE
1684
DELISTED
bluebird bio
BLUE
$230K 0.01%
928
+671
+261% +$192K
SYF icon
1685
Synchrony
SYF
$25.4B
$230K 0.01%
4,715
-10,485
-69% -$509K
AIT icon
1686
Applied Industrial Technologies
AIT
$13.2B
$229K 0.01%
2,539
-3,007
-54% -$265K
ARCT icon
1687
Arcturus Therapeutics
ARCT
$200M
$229K 0.01%
4,786
+3,386
+242% +$152K
CRON
1688
Cronos Group
CRON
$1.11B
$229K 0.01%
40,863
+31,707
+346% +$215K
ERY icon
1689
Direxion Daily Energy Bear 2X ETF
ERY
$37.4M
$229K 0.01%
+1,682
New +$269K
QNCX icon
1690
Quince Therapeutics
QNCX
$30M
$229K 0.01%
12
-10
-45% -$159K
WWW icon
1691
Wolverine World Wide
WWW
$1.55B
$229K 0.01%
7,667
-4,367
-36% -$149K
DAVA icon
1692
Endava
DAVA
$159M
$228K 0.01%
1,682
-618
-27% -$79.8K
MHO icon
1693
M/I Homes
MHO
$3.74B
$228K 0.01%
3,950
-8,649
-69% -$530K
NTRA icon
1694
Natera
NTRA
$45.9B
$228K 0.01%
2,041
-1,175
-37% -$135K
PLXS icon
1695
Plexus
PLXS
$7.13B
$228K 0.01%
2,544
+1,965
+339% +$175K
UBSI icon
1696
United Bankshares
UBSI
$6.55B
$228K 0.01%
6,275
-21,420
-77% -$749K
MYOV
1697
DELISTED
Myovant Sciences Ltd.
MYOV
$228K 0.01%
+10,150
New +$223K
ADNT icon
1698
Adient
ADNT
$1.44B
$227K 0.01%
5,473
-367
-6% -$14.6K
AKR icon
1699
Acadia Realty Trust
AKR
$2.78B
$227K 0.01%
11,121
+6,716
+152% +$142K
LFUS icon
1700
Littelfuse
LFUS
$11.6B
$227K 0.01%
830
-1,327
-62% -$354K
66 67
68
69 70

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.